abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common
Shares outstanding
29,948,325
Total 13F shares
4,081,292
Share change
+566,227
Total reported value
$71,163,712
Price per share
$17.43
Number of holders
62
Value change
+$10,150,880
Number of buys
39
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q4 2019

As of 31 Dec 2019, abrdn Life Sciences Investors - Common (HQL) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,081,292 shares. The largest 10 holders included NEEDHAM INVESTMENT MANAGEMENT LLC, MORGAN STANLEY, WOLVERINE ASSET MANAGEMENT LLC, FLAGSHIP HARBOR ADVISORS, LLC, COHEN & STEERS, INC., WELLS FARGO & COMPANY/MN, Cornerstone Advisors, LLC, Karpus Management, Inc., Advisors Asset Management, Inc., and 1832 Asset Management L.P.. This page lists 62 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.